Bellecapital’s iShares iBonds Dec 2020 Term Corporate ETF IBDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-37,061
Closed -$935K 194
2020
Q3
$935K Hold
37,061
0.43% 47
2020
Q2
$939K Hold
37,061
0.44% 50
2020
Q1
$934K Hold
37,061
0.6% 41
2019
Q4
$938K Hold
37,061
0.48% 43
2019
Q3
$940K Hold
37,061
0.56% 41
2019
Q2
$939K Hold
37,061
0.58% 35
2019
Q1
$935K Hold
37,061
0.59% 36
2018
Q4
$926K Buy
37,061
+20,481
+124% +$511K 0.66% 31
2018
Q3
$415K Hold
16,580
0.27% 59
2018
Q2
$415K Hold
16,580
0.3% 55
2018
Q1
$416K Buy
16,580
+2,080
+14% +$52.3K 0.39% 51
2017
Q4
$367K Buy
+14,500
New +$369K 0.3% 54

Other funds holding IBDL

Bellecapital's IBDL Position: Q4 2020 in Review

Bellecapital sold out of iShares iBonds Dec 2020 Term Corporate ETF (IBDL) in Q4 2020, closing a stake of 37,061 shares — an estimated $935K sold.

Bellecapital first reported a position in IBDL in Q4 2017 and held it in 12 quarters. The position peaked at $940K in Q3 2019. 1 fund tracked by Wall St. Rank holds IBDL as of Q4 2020.

  • Bellecapital reported no remaining iShares iBonds Dec 2020 Term Corporate ETF position as of Q4 2020 after selling out during the quarter.
  • Bellecapital sold 37,061 iShares iBonds Dec 2020 Term Corporate ETF shares in Q4 2020, an estimated $935K.
  • Bellecapital first reported a position in iShares iBonds Dec 2020 Term Corporate ETF in Q4 2017 and held it in 12 quarters.
  • Bellecapital's iShares iBonds Dec 2020 Term Corporate ETF position peaked at $940K in Q3 2019.
  • 1 fund tracked by Wall St. Rank held iShares iBonds Dec 2020 Term Corporate ETF as of Q4 2020.

Based on Bellecapital's 13F filing for Q4 2020, filed 14 Jan 2021.